Verana Health, Inc., based in San Francisco, provides real-world data analytics for healthcare providers and researchers.
Founded in 2008 and headquartered in San Francisco, US, Verana Health, Inc. provides real-world data and analytics focused on ophthalmic and urological conditions. Its products combine AI and machine learning with electronic health records for pharmaceutical companies and clinical research organizations. The company raised USD 150 mn in a Series E round in January 2022 from investors including Johnson & Johnson Innovation and Novo Holdings. Marc Berger is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in